Abbott Laboratories
Health Care Equipment
ABT
$ 112 (0.41)%
Share price
$ 196 bn
Market Cap
$ 202 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Abbott Laboratories aims to reduce Scope 1 + 2 by 30% by 2030 from a base year 2018
This target has not been verified as science based according to SBTi
GHG emissions and Carbon intensity
Abbott Laboratories reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 930 Kt (+30/+3.3% y-o-y). At the sime time, carbon intensity was down at 26 t (-4.2 /-13.9% y-o-y).
No public disclosure of Scope 3 emissions has been found for Abbott Laboratories at the moment.
The company is committed to reducing Scope 1 + 2 by 30% by 2030 from a base year 2018, which translates into the estimated reduction of -27 Kt per annum over the period of FY2022 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.
Copyright © 2023 Exerica. All rights reserved.